Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC

Emory University, Cancer Institute (WIA), KU Leuven, Institut Gustave Roussy, Yonsei University, Moffitt Cancer Center, National Cancer Center, Tongji University, Shanghai Pulmonary Hospital, Mahidol University, Ramathibodi Hospital, Jilin Province Tumor Hospital, Chiang Mai University, Maidstone and Tunbridge Wells NHS Trust, Maidstone Hospital, Instituto de Investigación Biomédica de Málaga, National University College, Chungbuk National University Hospital, New Generation University College, William Osler Health System, University of Toronto, University of Parma, Austin Health, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Osaka International Cancer Institute, Kansai Medical University, PCR Oncology, AstraZeneca (United States), Université Paris-Sud